TGTX Stock: Price, Earnings History and SEC Filings
TG Therapeutics, Inc. (TGTX) last traded at $61.18, up 5.34% on the latest session and up 9.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.05 against an analyst estimate of $0.41, a miss of 87.8%.
$61.18 +5.34%
1 month+9.68%
52-week high$61.76
52-week low$26.76
Volume2.86M
ExchangeNasdaqCM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
TGTX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 3, 2026 | $0.05 | $0.41 | -87.80% |
| Mar 2026 | May 6, 2026 | $0.17 | $0.23 | -26.09% |
| Dec 2025 | Feb 26, 2026 | $0.14 | $0.35 | -60.00% |
| Sep 2025 | Nov 3, 2025 | $2.43 | $0.24 | +912.50% |
TGTX beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for TGTX
SEC filing data is not available right now. You can search for TGTX on SEC EDGAR.
TGTX news
- EBay Leads Five Stocks Near Buy Points From Resilient SectorsOct 31, 2026 · finance.yahoo.com
- TG Therapeutics Is Up 98%, But The Story Isn't FinishedOct 30, 2026 · finance.yahoo.com
- TGTX Stock Hits Fresh 52-Week High Ahead Of Earnings Amid Buyout BuzzOct 30, 2026 · stocktwits.com
- GILD Beats Q3 Earnings on HIV Strength & Trodelvy Sales GrowthOct 30, 2026 · finance.yahoo.com
- INSM Q3 Earnings Miss, Stock Soars on Sales Beat & Raised GuidanceOct 30, 2026 · finance.yahoo.com
- Edwards' Q3 Earnings on the Horizon: What's in the Cards?Oct 30, 2026 · finance.yahoo.com
- INCY Q3 Loss Narrower Than Expected, Sales Beat, FY'26 View RaisedOct 29, 2026 · finance.yahoo.com
- VKTX Q3 Earnings Miss Estimates Amid Rising Clinical ExpensesOct 29, 2026 · finance.yahoo.com
About TG Therapeutics, Inc.
TG Therapeutics, Inc. (TGTX) is a US-listed public company on Nasdaq.